Skip to content

AnimAb

Active
Private limited companyfounded 20206 yrs activeTechnologiepark-Zwijnaarde 94, 9052 Gent, BelgiumKBO/BCE: BE 0747.674.614
Summary

The annual accounts of AnimAb for fiscal year 2024 show a net loss of 83% of total assets and of 104% of the equity at the start of that year. The 2024 annual accounts show equity of €4.1m and a net result of -€3.8m. Equity is growing by ~9.7% per year across the filed fiscal years. Its solvency ranks better than 84% of 226 sector peers (fiscal year 2024). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.0% (low).

Checked score

Score 2024
59 / 100
Fair
A net loss of at least half of total assets or of the equity at the start of the financial year caps the score. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability50=
Solvency100=
Growth52=
Track record100
Bankruptcy probability, 12 months
1.0% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €230,000 at 30 days only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity ample (current ratio 8.31 against 8.09 in 2023; short-term debt: 11.5% and cash: 75% of total assets), and 11.5% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 6 years 0 10 y
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Scientific research and development (NACE 72)
about 30% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
88.5%
Return on assets
-83.1%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 03-07-2025, 28 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
not confirmed
2024
28 d early
2023
50 d early
2022
61 d early
2021
52 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 48 days before the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 27 May 2020, AnimAb was incorporated as a Private limited company.1 Total assets went from EUR 3.6 million in 2021 to EUR 4.6 million in 2024 and headcount from 2.8 to 4.7 full-time equivalents.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2021 and 2024

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, abbreviated schema

Equity
€4.1m▲ 10.5%
2023 · €3.7m
Total assets
€4.6m▲ 11.4%
2023 · €4.1m
Net result
-€3.8m▼ 45.4%
2023 · -€2.6m
Working capital
€3.9m▲ 22.8%
2023 · €3.1m
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line2021202220232024
Operating result-€2.0m--€1.7m▲ 16.1%-€2.7m▼ 62.7%-€4.0m▼ 44.8%
Net result-€2.0mbelow the sector's middle half--€1.6mbelow the sector's middle half▲ 17.3%-€2.6mbelow the sector's middle half▼ 61.1%-€3.8mbelow the sector's middle half▼ 45.4%
Equity€2.9mabove the sector's middle half-€6.3mabove the sector's middle half▲ 115%€3.7mabove the sector's middle half▼ 41.6%€4.1mabove the sector's middle half▲ 10.5%
Total assets€3.6mwithin the sector's middle half-€6.7mabove the sector's middle half▲ 86.5%€4.1mwithin the sector's middle half▼ 38.2%€4.6mwithin the sector's middle half▲ 11.4%
Debt€645,848-€368,111▼ 43.0%€444,015▲ 20.6%€529,256▲ 19.2%
Working capital€2.4mabove the sector's middle half-€5.4mabove the sector's middle half▲ 126%€3.1mabove the sector's middle half▼ 42.2%€3.9mabove the sector's middle half▲ 22.8%
Solvency81.9%above the sector's middle half-94.5%above the sector's middle half▲ 12.5pp89.2%above the sector's middle half▼ 5.3pp88.5%above the sector's middle half▼ 0.8pp
Current ratio20.45above the sector's middle half-15.80above the sector's middle half▼ 4.668.09above the sector's middle half▼ 7.718.31above the sector's middle half▲ 0.22
Return on assets (ROA)-55.0%below the sector's middle half--24.4%below the sector's middle half▲ 30.6pp-63.7%below the sector's middle half▼ 39.3pp-83.1%below the sector's middle half▼ 19.4pp
Staff (FTE)2.8below the sector's middle half-3.4▲ 21.4%4.6within the sector's middle half▲ 35.3%4.7within the sector's middle half▲ 2.2%
above within below the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Why a figure moved sharply
  • 2023 Net result -61% on 2022. The accounts now follow the abbreviated schema, last year the micro schema.
Result per fiscal year
Operating resultNet result
-€4.0m-€3.0m-€2.0m-€1.0m€0Operating result 2021: -€2.0m-€2.0mNet result 2021: -€2.0m-€2.0mOperating result 2022: -€1.7m-€1.7mNet result 2022: -€1.6m-€1.6mOperating result 2023: -€2.7m-€2.7mNet result 2023: -€2.6m-€2.6mOperating result 2024: -€4.0m-€4.0mNet result 2024: -€3.8m-€3.8m2021202220232024-€4m-€3m-€2m-€1m€0Operating result 2022: -€1.7m-€1.7mNet result 2022: -€1.6m-€1.6mOperating result 2023: -€2.7m-€2.7mNet result 2023: -€2.6m-€2.6mOperating result 2024: -€4.0m-€4mNet result 2024: -€3.8m-€3.8m202220232024
The operating result stays negative: a loss of €4.0m in 2024 against €2.7m in 2023; the loss grows and 2024 has the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €4.6m
Fixed assets €195,960 ▼ 63.0%
Current assets €4.4m ▲ 22.4%
Equity and liabilities €4.6m
Equity €4.1m ▲ 10.5%
Debt €529,256 ▲ 19.2%
Debt's share of the balance-sheet total rises from 10.8% to 11.5%. Equity and debt are higher.
Key figures and ratios
2024 value · change against 2023
EBITDA
€171,090▲
2023 · €29,112
Cash flow
€328,580▲
2023 · €147,568
Debt to equity
0.13▲
2023 · 0.12
ROE
-93.9%▼
2023 · -71.4%
Interest coverage
23.21▲
2023 · 12.91
Debt ≤ 1 year
€529,256▲
2023 · €444,015
Income taxes
-€164,856▼
2023 · -€120,612
Staff costs
€461,438▲
2023 · €354,740
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 3,597 companies that looked in July 2024 the way this one looks now, 2.8% went bankrupt within 24 months and 87% are still going.

  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a loss of 10% of the balance sheet or more
2.8% went bankrupt
9.2% stopped otherwise
87% still going

A further 0.8% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 1.0% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.7%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 3,597 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 41 lines
Balance sheet Code20232024
Assets
Total assets20/58€4.1m€4.6m▲
Fixed assets21/28€529,315€195,960▼
Intangible fixed assets21€425,000€125,000▼
Tangible fixed assets22/27€104,315€70,960▼
Plant, machinery and equipment23€97,398€64,948▼
Furniture and vehicles24€6,918€6,012▼
Current assets29/58€3.6m€4.4m▲
Amounts receivable after more than one year29€234,935€401,589▲
Other amounts receivable291€234,935€401,589▲
Amounts receivable within one year40/41€118,508€341,479▲
Trade receivables40€0€84,351▲
Other amounts receivable41€118,508€257,128▲
Cash at bank and in hand54/58€3.2m€3.4m▲
Deferred charges and accrued income490/1€11,181€210,061▲
Equity and liabilities
Total equity and liabilities10/49€4.1m€4.6m▲
Equity10/15€3.7m€4.1m▲
Contributions10/11€9.9m€14.1m▲
Profit (loss) carried forward14-€6.2m-€10.0m▼
Amounts payable17/49€444,015€529,256▲
Amounts payable within one year42/48€444,015€529,256▲
Trade debts44€404,563€465,239▲
Suppliers440/4€404,563€465,239▲
Taxes, remuneration and social security45€39,452€64,017▲
Taxes450/3€0-
Remuneration and social security454/9€39,452€64,017▲
Income statement Code20232024
Remuneration, social security and pensions62€354,740€461,438▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2.8m€4.1m▲
Other operating charges640/8€305€1,258▲
Gross operating margin9900€384,157€633,786▲
Operating profit (loss)9901-€2.7m-€4.0m▼
Financial income75/76B€98€6▼
Recurring financial income75€98€6▼
Financial charges65/66B€2,254€7,372▲
Recurring financial charges65€2,254€7,372▲
Profit (loss) for the period before taxes9903-€2.7m-€4.0m▼
Income taxes67/77-€120,612-€164,856▼
Profit (loss) for the period9904-€2.6m-€3.8m▼
Profit (loss) for the period to be appropriated9905-€2.6m-€3.8m▼
Appropriation of the result
Profit (loss) to be appropriated9906-€6.2m-€10.0m▼
Profit (loss) brought forward from the previous period14P-€3.6m-€6.2m▼
Social balance
Average headcount (FTE)90874.64.7▲

The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2021202220232024Change
Remuneration, social security and pensions62€308,652€302,396€354,740€461,438▲ 30.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1.9m€1.9m€2.8m€4.1m▲ 49.5%
Other operating charges640/8€1,247€467€305€1,258▲ 313%
Gross operating margin9900€172,219€503,327€384,157€633,786▲ 65.0%
Operating profit (loss)9901-€2.0m-€1.7m-€2.7m-€4.0m▼ 44.8%
Financial income75/76B€766€83€98€6▼ 93.7%
Recurring financial income75€766€83€98€6▼ 93.7%
Financial charges65/66B€9,601€9,026€2,254€7,372▲ 227%
Recurring financial charges65€9,601€9,026€2,254€7,372▲ 227%
Profit (loss) for the period before taxes9903-€2.0m-€1.7m-€2.7m-€4.0m▼ 45.0%
Income taxes67/77-€48,388-€65,935-€120,612-€164,856▼ 36.7%
Profit (loss) for the period9904-€2.0m-€1.6m-€2.6m-€3.8m▼ 45.4%
Profit (loss) for the period to be appropriated9905-€2.0m-€1.6m-€2.6m-€3.8m▼ 45.4%
Line2021202220232024Change
Assets
Total assets20/58€3.6m€6.7m€4.1m€4.6m▲ 11.4%
Fixed assets21/28€1.0m€855,119€529,315€195,960▼ 63.0%
Intangible fixed assets21€1.0m€726,711€425,000€125,000▼ 70.6%
Tangible fixed assets22/27€9,711€128,408€104,315€70,960▼ 32.0%
Plant, machinery and equipment23€9,711€120,090€97,398€64,948▼ 33.3%
Furniture and vehicles24-€8,318€6,918€6,012▼ 13.1%
Current assets29/58€2.5m€5.8m€3.6m€4.4m▲ 22.4%
Amounts receivable after more than one year29€206,375€114,322€234,935€401,589▲ 70.9%
Other amounts receivable291€206,375€114,322€234,935€401,589▲ 70.9%
Amounts receivable within one year40/41€416,479€271,754€118,508€341,479▲ 188%
Trade receivables40€31,398€473€0€84,351-
Other amounts receivable41€385,081€271,281€118,508€257,128▲ 117%
Cash at bank and in hand54/58€1.9m€5.4m€3.2m€3.4m▲ 6.7%
Deferred charges and accrued income490/1€13,915€0€11,181€210,061▲ 1,779%
Equity and liabilities
Total equity and liabilities10/49€3.6m€6.7m€4.1m€4.6m▲ 11.4%
Equity10/15€2.9m€6.3m€3.7m€4.1m▲ 10.5%
Contributions10/11€4.9m€9.9m€9.9m€14.1m▲ 42.4%
Outside capital11€4.9m----
Other1109/19€4.9m----
Profit (loss) carried forward14-€2.0m-€3.6m-€6.2m-€10.0m▼ 61.3%
Amounts payable17/49€645,848€368,111€444,015€529,256▲ 19.2%
Amounts payable within one year42/48€124,108€368,111€444,015€529,256▲ 19.2%
Trade debts44€92,597€322,736€404,563€465,239▲ 15.0%
Suppliers440/4€92,597€322,736€404,563€465,239▲ 15.0%
Taxes, remuneration and social security45€31,511€45,376€39,452€64,017▲ 62.3%
Taxes450/3-€395€0--
Remuneration and social security454/9€31,511€44,981€39,452€64,017▲ 62.3%
Accrued charges and deferred income492/3€521,740€0---
Line2021202220232024Change
Profit (loss) for the period9904-€2.0m-€1.6m-€2.6m-€3.8m▼ 45.4%
+ Depreciation and write-downs630€1.9m€1.9m€2.8m€4.1m▲ 49.5%
Operating cash flow (approximation)-€98,126€257,456€147,568€328,580▲ 123%
Investment in fixed assets (approximation)--€1.7m-€2.4m-€3.8m▼ 55.8%
Change in cash-€3.5m-€2.2m€215,118▲ 110%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2025
03-07
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial Weakest financial yearnet -€3.8m
Net result drops to -€3.8m, the lowest in the series.
11-06
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-05
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial Equity above €5mEq €6.3m ▲115%
Equity rises from €2.9m to €6.3m.
09-06
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 15 acts read
About the unread acts

We know of 15 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
15 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2020
seat establishment The establishment unit on the map
Ground area
1.2 ha
Building footprint
1,291 m²
Volume, LiDAR
18,399 m³
Parcel 44082B0081/00F000, Flanders · tallest building 15.3 m, ±5 floors. Linked by address, not a title deed.
8 companies at this address See who is registered here
1 establishment unit
AnimAb
Technologiepark-Zwijnaarde 94, 9052 GentManufacture of basic pharmaceutical products and pharmaceutical preparations
since 20202.307.502.415
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44082B0081/00F000 Flanders 1.2 ha 1 · 1,291 m² 15.3 m · 5 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

4 owners

According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Public money · subsidies and aid

Flemish government

2023 to 2025 · 4 entries · 983,204 EUR awarded · 983,204 EUR paid
Year Entries awardedpaid
2025 2 0 EUR197,204 EUR
2024 1 0 EUR393,000 EUR
2023 1 983,204 EUR393,000 EUR
Schemes
4 entries · 983,204 EUR · 983,204 EUR paid · Fonds voor Innoveren en Ondernemen

Recognitions · licences · registrations

Legal Entity Identifier

9845008549A89982E721
live in the LEI register

Similar companies · same sector, comparable size

Of 1,177 companies in sector 72109 we hold annual accounts for 717. 322 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded27-05-2020
Fiscal year end31-12
Activities, NACEBEL 2025
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
72109Other research and development on natural sciences
74999Other professional, scientific and technical activities
E-invoicing
Reachable via Peppol
Peppol ID 0208:0747674614
Registered 06-01-2026

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.